Saturday, October 31, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Data updated Oct 31, 2026·New filings added every weekday·Weekly prices as of Oct 2·What changed·
Insider tradingForm 4

Day One Biopharmaceuticals, Inc. (DAWN) Insider Trading

5 open-market trades reported since Feb 18, 2026: 0 purchases worth $0 and 5 sales worth $423K.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Jeremy BenderCEO0$01$179KFeb 18, 2026
Adam DubowSecretary0$01$74KFeb 18, 2026
Charles N. York IICFO0$01$70KFeb 18, 2026
Lauren MerendinoChief Commercial Officer0$01$67KFeb 18, 2026
Michael VasconcellesHead of Research and Dev.0$01$32KFeb 18, 2026

All trades

DAWN insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Feb 18Feb 17Jeremy BenderCEOCEO▼ SELL15,45911.60$179K−7.0%Form 4 ↗
Feb 18Feb 17Adam DubowSecretarySecretary▼ SELL6,39511.60$74K−8.1%Form 4 ↗
Feb 18Feb 17Charles N. York IICFOCFO▼ SELL6,06511.60$70K−1.9%Form 4 ↗
Feb 18Feb 17Lauren MerendinoChief Commercial OfficerChief Commercial Officer▼ SELL5,81411.60$67K−8.8%Form 4 ↗
Feb 18Feb 17Michael VasconcellesHead of Research and Dev.Head of Research and Dev.▼ SELL2,72811.60$32K−38%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 31, 2026. How we read filings

Report an error

Tell us what looks wrong on this page. We check every report against the original filing and fix mistakes on our corrections page.

Share this trade
XTelegram
My Desk · free

Sign in to follow

Follow stocks, members of Congress, famous investors and funds, and see what's new each time you come back.